MetLife Investment Management’s PAE Incorporated Class A Common Stock PAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-16,971
Closed -$169K 2802
2021
Q4
$169K Sell
16,971
-7,875
-32% -$70.3K ﹤0.01% 2161
2021
Q3
$149K Buy
24,846
+14,126
+132% +$108K ﹤0.01% 2260
2021
Q2
$95.4K Sell
10,720
-12,772
-54% -$110K ﹤0.01% 2406
2021
Q1
$212K Buy
23,492
+9,425
+67% +$84K ﹤0.01% 2024
2020
Q4
$129K Sell
14,067
-5,701
-29% -$52.7K ﹤0.01% 2187
2020
Q3
$168K Sell
19,768
-9,087
-31% -$81K ﹤0.01% 1961
2020
Q2
$276K Buy
+28,855
New +$257K ﹤0.01% 1709

MetLife Investment Management's PAE Position: Q1 2022 in Review

MetLife Investment Management sold out of PAE Incorporated Class A Common Stock (PAE) in Q1 2022, closing a stake of 16,971 shares — an estimated $169K sold.

MetLife Investment Management first reported a position in PAE in Q2 2020 and held it in 7 quarters. The position peaked at $276K in Q2 2020. 0 funds tracked by Wall St. Rank hold PAE as of Q1 2022.

  • MetLife Investment Management reported no remaining PAE Incorporated Class A Common Stock position as of Q1 2022 after selling out during the quarter.
  • MetLife Investment Management sold 16,971 PAE Incorporated Class A Common Stock shares in Q1 2022, an estimated $169K.
  • MetLife Investment Management first reported a position in PAE Incorporated Class A Common Stock in Q2 2020 and held it in 7 quarters.
  • MetLife Investment Management's PAE Incorporated Class A Common Stock position peaked at $276K in Q2 2020.
  • 0 funds tracked by Wall St. Rank held PAE Incorporated Class A Common Stock as of Q1 2022.

Based on MetLife Investment Management's 13F filing for Q1 2022, filed 12 May 2022.